ASEAN five to adopt drug exports standards
The Geneva-headquartered International Federation of Pharmaceutical Manufacturers and Associations says that several members of the Association of South-East Asian Nations (Malaysia, Singapore, Thailand, Indonesia and Vietnam) are maintaining their goal of the adoption of common standards for the documentation of pharmaceuticals exports, by the end of the year.
The move is designed to slash the tariff costs and remove the layers of red tape, in order to make the unified Chinese drug market more attractive to manufacturers. Malaysian Trade Minister Rafidah Aziz said that the adoption of standards across the region would expedite the flow of goods and keep costs to a minimum.
The IFPMA added that other members of the ASEAN (Cambodia, Laos, Myanmar and the Philippines) are expected to implement the standards by December 31, 2008. ASEAN has also agreed to adopt a "standstill" on non-tariff barriers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze